Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Gynecologic Oncology · Squamous Cell Carcinoma of the Cervix

Treatment for Early-Stage Disease and Fertility Options

At a Glance

Early-stage squamous cell cervical cancer may be treated with conization, hysterectomy, or chemoradiation based on tumor size, depth of invasion, lymph nodes, and fertility goals. Carefully selected patients may preserve the uterus with radical trachelectomy.

When squamous cell carcinoma of the cervix is caught in its early stages (FIGO IA1 through IB2), you often have several surgical options. The goal of treatment at this stage is to remove the cancer completely while preserving as much function—and sometimes fertility—as possible [1].

Choosing the Right Surgery

The type of surgery your doctor recommends depends heavily on how deeply the cancer has invaded the cervix and whether it has entered the “pipes” of the tissue, known as lymphovascular space invasion (LVSI) [1][2].

  • Cone Biopsy (Conization): For very early microscopic cancer (Stage IA1) with no signs of LVSI, a cone-shaped piece of the cervix may be all that is needed, often alongside an assessment of the lymph nodes [1].
  • Simple Hysterectomy: If fertility is not a concern, a simple hysterectomy (removing the uterus and cervix) is often standard for Stage IA1 [3]. Selected IA2 and small IB1 tumors may also be managed with simple hysterectomy or conization plus lymph-node assessment in appropriate cases.
  • Radical Hysterectomy: For larger early-stage cancers or those with LVSI (some IA2 through IB2), a radical hysterectomy is frequently considered [2]. This involves removing the uterus, the cervix, the upper part of the vagina, and the parametrium (the connective tissue next to the cervix) [4].
  • Primary Chemoradiation: For larger IB2 tumors (2 to 4 cm), surgery is not the only choice. Depending on nodal assessment, your overall health, and the high likelihood of needing radiation after surgery anyway, primary chemoradiation may be recommended as a better alternative to avoid the compounded side effects of both treatments [5][6].

Why the Surgical Approach Matters: The LACC Trial

In many types of surgery, “minimally invasive” (laparoscopic or robotic) approaches are preferred because they offer faster recovery. However, for radical hysterectomy in cervical cancer, the evidence strongly favors open abdominal surgery [7].

A landmark international study called the LACC trial compared the two methods. It found that women who had minimally invasive surgery had a higher risk of the cancer returning and a lower overall survival rate than those who had open surgery [7][8].

  • At 4.5 years, 96.5% of women in the open surgery group were alive without disease recurrence, compared to 86% in the minimally invasive group [7].
  • While minimally invasive surgery may result in less blood loss and shorter hospital stays, open surgery remains the standard of care because of these superior long-term survival outcomes [9][10].

Preserving Your Fertility and Hormones

If you wish to maintain the ability to carry a pregnancy, fertility-sparing surgery may be an option, but it requires strict selection and should be discussed with a gynecologic oncologist and reproductive endocrinologist before treatment.

Radical Trachelectomy

This procedure removes the cervix and the parametrium but leaves the body of the uterus intact [11]. To be a candidate, the tumor typically must be:

  • Approximately 2 centimeters or smaller [12].
  • Confined to the cervix with favorable histology, appropriate depth/LVSI, and no spread to the parametrium or lymph nodes [13][14].

A permanent stitch (cerclage) is usually placed to help support a future pregnancy [15]. While many women have successfully had children after this surgery, the pregnancy is considered high-risk, often requiring specialist obstetric care and cesarean delivery [16]. Furthermore, if positive lymph nodes or margins are found during surgery, the plan may change to include chemoradiation.

Ovarian Preservation

Ovarian preservation means leaving the ovaries in place to maintain natural hormones; it does not preserve the ability to carry a pregnancy if the uterus is removed [17]. This allows your body to continue producing hormones naturally, avoiding immediate surgical menopause [18]. Be aware that if you need pelvic radiation after surgery, it can still cause ovarian failure, even if the ovaries are left in place. Moving the ovaries higher in the abdomen (ovarian transposition) can reduce but does not completely eliminate this risk.

When Radiation is Needed After Surgery

Sometimes, even after a successful surgery, your pathology report will show features that suggest a higher risk of recurrence. In these cases, adjuvant therapy (additional treatment) is recommended.

Doctors use criteria to decide if you need radiation or chemoradiation:

  1. High-Risk (Peters Criteria): If cancer is found in the lymph nodes, at the surgical margins (the edges of the removed tissue), or in the parametrium, doctors generally recommend chemoradiation (radiation combined with cisplatin) [19][20].
  2. Intermediate-Risk (Sedlis Criteria): If you have a specific combination of tumor size, deep stromal invasion, and LVSI, your doctor may recommend radiation alone to the pelvis to reduce the chance of the cancer coming back [20][21].

Common questions in this guide

What surgery might treat early-stage squamous cell cervical cancer?
The choice depends on tumor size, how deeply it has grown, whether cancer cells are in small blood or lymph vessels, lymph nodes, and pregnancy goals. A cone biopsy may be sufficient for some stage IA1 cancers without this vessel involvement, while a simple or radical hysterectomy may be used for other early-stage tumors. Lymph-node assessment is often part of treatment planning.
Why is open abdominal surgery often recommended for a radical hysterectomy?
For radical hysterectomy in cervical cancer, the LACC trial found that minimally invasive surgery had higher recurrence and lower overall survival than open abdominal surgery. Minimally invasive surgery may mean less blood loss and a shorter hospital stay, but open surgery remains standard when radical hysterectomy is chosen because long-term cancer control is the priority.
Can fertility be preserved after treatment for early-stage cervical cancer?
Some carefully selected patients with tumors about 2 centimeters or smaller, confined to the cervix, with favorable features and no spread to lymph nodes or the tissue beside the cervix may be candidates for radical trachelectomy. This operation removes the cervix and nearby tissue but leaves the body of the uterus, and a permanent stitch is usually placed. Pregnancy afterward is high risk and often requires specialist obstetric care and cesarean delivery.
Does preserving my ovaries preserve fertility?
No. Leaving the ovaries in place can maintain natural hormone production and avoid immediate surgical menopause, but it does not allow you to carry a pregnancy if the uterus is removed. Pelvic radiation can still cause the ovaries to stop working; moving them higher in the abdomen may reduce but does not eliminate this risk.
When might I need radiation or chemoradiation after surgery?
Chemoradiation, usually radiation with cisplatin, is generally recommended when cancer is found in lymph nodes, at surgical margins, or in the tissue beside the cervix. Radiation alone may be recommended when a combination of tumor size, deep invasion into the cervix, and lymphovascular space invasion raises recurrence risk. The final recommendation depends on your pathology and overall treatment plan.
Is chemoradiation an alternative to surgery for an IB2 cervical tumor?
For some 2-to-4-centimeter IB2 tumors, primary chemoradiation may be considered instead of surgery. The decision depends on lymph-node findings, overall health, and the likelihood that surgery would be followed by radiation or chemotherapy. A gynecologic oncologist should compare the potential benefits and side effects of both approaches.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my tumor size and pathology, am I a candidate for less radical surgery or fertility-sparing surgery?
  2. 2.Will my radical hysterectomy be performed as an 'open' abdominal surgery, and why is that the recommended approach?
  3. 3.If we choose surgery for my IB2 tumor, how likely is it that I will still need radiation or chemotherapy afterward?
  4. 4.What exact criteria (like depth, size, and LVSI) will you use to determine if I need postoperative radiation?
  5. 5.Should I speak to a reproductive endocrinologist before treatment to discuss egg or embryo preservation?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Management of Early Stage Cervical Cancer.

    Somashekhar SP, Ashwin KR

    Reviews on recent clinical trials 2015; (10(4)):302-8 doi:10.2174/1574887110666150923113629.

    PMID: 26411950
  2. 2

    Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility-Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer.

    Zusterzeel PLM, Aarts JWM, Pol FJM, et al.

    The oncologist 2020; (25(7)):e1051-e1059 doi:10.1634/theoncologist.2020-0063.

    PMID: 32339376
  3. 3

    ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer.

    Schmeler KM, Pareja R, Lopez Blanco A, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2021; (31(10)):1317-1325 doi:10.1136/ijgc-2021-002921.

    PMID: 34493587
  4. 4

    Revised FIGO staging for carcinoma of the cervix uteri.

    Bhatla N, Berek JS, Cuello Fredes M, et al.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2019; (145(1)):129-135 doi:10.1002/ijgo.12749.

    PMID: 30656645
  5. 5

    The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.

    Hwang WY, Kim JH, Suh DH, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020; (30(7)):975-980 doi:10.1136/ijgc-2020-001271.

    PMID: 32467336
  6. 6

    Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer.

    Nama V, Angelopoulos G, Twigg J, et al.

    The Cochrane database of systematic reviews 2018; (10()):CD011478 doi:10.1002/14651858.CD011478.pub2.

    PMID: 30311942
  7. 7

    Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.

    Ramirez PT, Frumovitz M, Pareja R, et al.

    The New England journal of medicine 2018; (379(20)):1895-1904 doi:10.1056/NEJMoa1806395.

    PMID: 30380365
  8. 8

    Changing treatment landscape for early cervical cancer: outcomes reported with minimally invasive surgery compared with an open approach.

    Melamed A, Ramirez PT

    Current opinion in obstetrics & gynecology 2020; (32(1)):22-27 doi:10.1097/GCO.0000000000000598.

    PMID: 31815768
  9. 9

    Laparoscopic versus open radical hysterectomy in women with early stage cervical cancer: A systematic review and meta-analysis.

    Tantitamit T, Huang KG, Lee CL

    Taiwanese journal of obstetrics & gynecology 2020; (59(4)):481-488 doi:10.1016/j.tjog.2020.05.003.

    PMID: 32653117
  10. 10

    Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer: A Systematic Review and Meta-analysis.

    Nitecki R, Ramirez PT, Frumovitz M, et al.

    JAMA oncology 2020; (6(7)):1019-1027 doi:10.1001/jamaoncol.2020.1694.

    PMID: 32525511
  11. 11

    Fertility-sparing trachelectomy for early-stage cervical cancer: A proposal of an ideal candidate.

    Machida H, Iwata T, Okugawa K, et al.

    Gynecologic oncology 2020; (156(2)):341-348 doi:10.1016/j.ygyno.2019.11.021.

    PMID: 31767188
  12. 12

    Fertility Preservation in Cervical Cancer-Treatment Strategies and Indications.

    Salman L, Covens A

    Current oncology (Toronto, Ont.) 2024; (31(1)):296-306 doi:10.3390/curroncol31010019.

    PMID: 38248104
  13. 13

    Survival after sentinel node biopsy alone in early-stage cervical cancer: a systematic review.

    Mauro J, Viveros-Carreño D, Vizzielli G, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023; (33(9)):1370-1375 doi:10.1136/ijgc-2023-004692.

    PMID: 37586759
  14. 14

    Fertility Sparing Treatment in Gastric-Type Endocervical Carcinoma.

    Rychlik A, Querleu D, Bidzinski M

    Cancers 2021; (13(20)) doi:10.3390/cancers13205177.

    PMID: 34680326
  15. 15

    After Radical Trachelectomy: Reproductive and Obstetrical Outcomes of Fertility-Sparing Surgery for Cervical Cancer.

    Soltanizadeh S, Rosendahl M, Frøding LP, et al.

    Seminars in reproductive medicine 2025; (43(1)):11-15 doi:10.1055/s-0045-1808092.

    PMID: 40245928
  16. 16

    Radical vaginal trachelectomy: long-term oncologic and fertility outcomes in patients with early cervical cancer.

    Kohler C, Plaikner A, Siegler K, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2024; (34(6)):799-805.

    PMID: 38599782
  17. 17

    Role of human papillomavirus status in the classification, diagnosis, and prognosis of malignant cervical epithelial tumors and precursor lesions.

    Stolnicu S

    Pathologie (Heidelberg, Germany) 2025; doi:10.1007/s00292-025-01517-8.

    PMID: 41335338
  18. 18

    Is parametrectomy always necessary in early-stage cervical cancer?

    Baiocchi G, de Brot L, Faloppa CC, et al.

    Gynecologic oncology 2017; (146(1)):16-19 doi:10.1016/j.ygyno.2017.03.514.

    PMID: 28392128
  19. 19

    Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort.

    Trifiletti DM, Swisher-McClure S, Showalter TN, et al.

    International journal of radiation oncology, biology, physics 2015; (93(5)):1032-44.

    PMID: 26581141
  20. 20

    The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I-II cervical cancer: A review.

    Takekuma M, Kasamatsu Y, Kado N, et al.

    The journal of obstetrics and gynaecology research 2017; (43(4)):617-626 doi:10.1111/jog.13282.

    PMID: 28190285
  21. 21

    Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor.

    Kim H, Park W, Kim YS, Kim YJ

    Journal of gynecologic oncology 2020; (31(3)):e35 doi:10.3802/jgo.2020.31.e35.

    PMID: 31912685

This page is for informational purposes only and does not constitute medical advice about early-stage cervical cancer. Your gynecologic oncologist and reproductive endocrinologist can interpret your pathology and discuss surgery, fertility, and radiation options for your situation.

Get notified when new evidence is published on Squamous cell carcinoma of the cervix uteri.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.